ALLMedicine Dysfunctional Uterine Bleeding Center

Jan 2nd, 2020 - The aim of this systematic review is to summarize the current evidence regarding the effectiveness of hysterectomy and hysteroscopic endometrial resection in improving quality of life (QoL), sexual function and psychological wellbeing of women abn...

Jul 7th, 2019 - Background Abnormal uterine bleeding (AUB), an updated term for dysfunctional uterine bleeding (DUB), is classically defined as excessively heavy, prolonged, or frequent bleeding of uterine origin that is not caused by pregnancy or recognizable pe...

Jul 7th, 2019 - Background Abnormal uterine bleeding (AUB), an updated term for dysfunctional uterine bleeding (DUB), is classically defined as excessively heavy, prolonged, or frequent bleeding of uterine origin that is not caused by pregnancy or recognizable pe...

Jun 6th, 2019 - Hysterectomy for benign gynecologic diseases, especially dysfunctional uterine bleeding, is one of the most common gynecologic interventions. The uterus can be removed using abdominal, vaginal, laparoscopic, or robotic-assisted laparoscopic hyster...

Apr 9th, 2019 - Dyspareunia, vaginitis and dysfunctional uterine bleeding (DUB) are common problems which, despite their polygenicity, commonly appear idiopathic and treatment-refractory. Mast cell (MC) activation syndrome (MCAS) is a newly-recognised, prevalent,...

Jan 17th, 2020 - ZOLADEX is a Gonadotropin Releasing Hormone (GnRH) agonist indicated for: Use in combination with flutamide for the management of locally confined carcinoma of the prostate (1.1) Palliative treatment of advanced carcinoma of the prostate (1.2) The...

Jan 2nd, 2020 - The aim of this systematic review is to summarize the current evidence regarding the effectiveness of hysterectomy and hysteroscopic endometrial resection in improving quality of life (QoL), sexual function and psychological wellbeing of women abn...

Aug 14th, 2019 - ZOLADEX is a Gonadotropin Releasing Hormone (GnRH) agonist indicated for: Use in combination with flutamide for the management of locally confined carcinoma of the prostate (1.1) Palliative treatment of advanced carcinoma of the prostate (1.2) The...

Jul 7th, 2019 - Background Abnormal uterine bleeding (AUB), an updated term for dysfunctional uterine bleeding (DUB), is classically defined as excessively heavy, prolonged, or frequent bleeding of uterine origin that is not caused by pregnancy or recognizable pe...

Jul 7th, 2019 - Background Abnormal uterine bleeding (AUB), an updated term for dysfunctional uterine bleeding (DUB), is classically defined as excessively heavy, prolonged, or frequent bleeding of uterine origin that is not caused by pregnancy or recognizable pe...

Mar 3rd, 2011 - A supplement to Family Practice News. Supported by an educational grant from Gynecare Worldwide, a division of Ethicon, Inc.

Dec 10th, 2006 - Dysfunctional Uterine Bleeding Several high-quality lectures at this year's AAFP Scientific Assembly highlighted healthcare for the female population, with particular attention to healthcare during the childbearing years. The series began with a d...

May 10th, 2004 - Question This is actually a comment for Dr. Kaunitz about the PCOS/morbid obesity question (see http://www.medscape.com/viewarticle/467101). I have seen some morbidly obese patients whose bleeding was controlled only with substantial doses of nore...

Oct 2nd, 2002 - Oct. 4, 2002 — Tissue plasminogen activator (tPA) appears to be safe for menstruating women, according to a case report and literature review published in the October issue of Stroke. However, doctors need to be aware of an increased risk of bleed...

LAS VEGAS — Endometrial ablation as a treatment for dysfunctional uterine bleeding achieves symptom relief comparable in the short term to a hysterectomy, with less morbidity, Dr. Malcolm G.